Cardlytics (CDLX) Tops Q1 EPS by 13c

Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.23), $0.13 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
• Exelon (EXC) PT Lowered to $49 at Argus